Skip to search formSkip to main content

AVE 1330A

Known as: AVE-1330A, AVE1330A 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
OBJECTIVE To review the chemistry, pharmacology, microbiology, pharmacokinetics, pharmacodynamics, clinical efficacy, safety… Expand
Is this relevant?
Review
2014
Review
2014
Avibactam (NXL104, AVE1330A) is a semi-synthetic, non-β-lactam, β-lactamase inhibitor that is active against Ambler class A… Expand
  • figure 1
  • figure 2
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2013
Review
2013
Avibactam (formerly NXL104, AVE1330A) is a synthetic non-β-lactam, β-lactamase inhibitor that inhibits the activities of Ambler… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 3
Is this relevant?
2004
2004
OBJECTIVES Production of beta-lactamases is the main mechanism of beta-lactam resistance in Gram-negative bacteria. Despite the… Expand
Is this relevant?